Card image cap

Federal Vaccine Mandates: What Both Private and Public Sector Employers Need to Know

Level: Advanced
Runtime: 62 minutes
Recorded Date: February 24, 2022
Click here to share this program
Printer-Friendly Version
Closed Caption


  • Resources & Introduction
  • EEO Laws and COVID-19 Screening of Workers Physically Entering the Workplace
  • COVID-19 and ADA Reasonable Accommodation
  • ADA Confidentiality Requirements
  • Workplace Infection Control Policies, Including Vaccination Requirements
  • Retaliation and Interference
  • Conclusion
Runtime: 1 hour, 2 minutes
Recorded: February 24, 2022

For NY - Difficulty Level: For experienced attorneys only (non-transitional)


Many employers, both private and public, are either subject to COVID-19 vaccination requirements or choosing to implement them. These requirements must allow exceptions as required under Title VII of the Civil Rights Act of 1964 (for sincerely held religious beliefs, practices, or observances) or the Americans with Disabilities Act/the Rehabilitation Act (for disability).

This program was recorded on February 24th, 2022.

Provided By

American Bar Association
Card image cap


Card image cap

Carol R. Miaskoff

Associate Legal Counsel
EEOC (Equal Employment Opportunity Commission)

Carol R. Miaskoff is the Associate Legal Counsel of the Equal Employment Opportunity Commission (Commission or EEOC). As deputy director of the Office of Legal Counsel, she is responsible for managing development of the Commission regulations and guidance under the Americans with Disabilities Act, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Equal Pay Act, and the Genetic Information Nondiscrimination Act. She also provides legal advice to the Commission on a wide range of matters, and works with the Department of Justice to defend the Chair and the Commission in litigation when stakeholders challenge Commission rules, guidance, and actions in court.

During her career at the EEOC, Miaskoff has supervised the development of proposed Commission policy on workplace harassment and final Commission guidance on retaliation and national origin discrimination. She served as a member of the EEOC’s equal pay task force and speaks frequently to labor and employment groups about issues ranging from the use of big data in employment to psychiatric disabilities and the ADA.

Miaskoff graduated from Harvard University and from the George Washington University Law School, with high honors. In the community, Miaskoff has been active in the Montgomery County, MD, Mental Health Advisory Committee, and guest lectures at a Georgetown University undergraduate class on Women and the Law.

Card image cap

Similar Courses

Card image cap
60 minutes
An Administration Update on the New Regulatory and Enforcement Landscape
With the ushering in of a new administration, companies and their counsel will need to update their compliance measures to reflect the changing enforcement priorities of regulatory agencies, state Attorney Generals, and the DOJ. Hear from industry leaders to help you prepare for the upcoming changes and provide a road map for stress-free compliance.

Women, Influence & Power in Law Conference


Add to Cart
Card image cap
55 minutes
Analyzing the Impact of U.S. Data Privacy Regulations
The discussion will focus on the latest developments with the California and other states’ privacy initiatives as well as the future of data privacy within the U.S. and how in-house counsel can prepare effectively. Specifically, our panelists will explore how to adapt your privacy operations and what is the scope of the application for each regulation.

General Counsel Conference


Add to Cart
Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute


Add to Cart
Card image cap
76 minutes
But I’m Afraid of Needles: The Sale of Health Care Assets
This panel will discuss various issues and challenges accompanying sales of health care assets, including factors to consider in determining whether or not a sale is the best alternative. Such factors include the role of regulatory authorities, political challenges, reimbursement issues, issues related to urban vs. rural facilities, the evolution of the health care business, and best practices in navigating such challenges.

American Bankruptcy Institute


Add to Cart
Previous Next